{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-047848","form_type":"8-K","ticker":null,"cik":"0001012477","company_name":"AVADEL PHARMACEUTICALS PLC","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.145651+00:00","generated_at":"2026-05-21T12:20:32.893582+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avadel appoints Susan Rodriguez as COO; base salary $510K, 300K options","bullets":["Susan Rodriguez appointed as COO effective May 13, 2025; role is newly created.","Base salary $510K, bonus potential 45% of salary, stock options for 300,000 shares vesting over 4 years.","Previously served as Chief Commercial Officer at Ardelyx and CEO at Tolmar Pharmaceuticals.","Appointment comes during LUMRYZ launch for narcolepsy; potential label expansion to idiopathic hypersomnia."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-047848","json":"https://secwatch.observer/filing/0001104659-25-047848.json","markdown":"https://secwatch.observer/filing/0001104659-25-047848.md","text":"https://secwatch.observer/filing/0001104659-25-047848.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1012477/000110465925047848/0001104659-25-047848-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1012477/000110465925047848/tm2514853d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T12:20:32.893582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b60f6700a","claim":"Susan Rodriguez was appointed as Chief Operating Officer at AVADEL PHARMACEUTICALS PLC.","evidence_excerpt":"Effective May 13, 2025, the Board of Directors (the “Board”) of Avadel Pharmaceuticals plc (the “Company”) appointed Susan Rodriguez as the Company’s Chief Operating Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1012477/000110465925047848/0001104659-25-047848-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}